Cell-Penetrating Drug Carrier by Molecular Recognition of Sphingomyelin on Plasma Membranes.
Langmuir
; 40(19): 9975-9984, 2024 May 14.
Article
en En
| MEDLINE
| ID: mdl-38695640
ABSTRACT
Plasma membranes not only maintain the intracellular microenvironment through their phospholipid bilayer but also eliminate exogenous compounds outside the cell membranes. Most drugs especially with high polarity are prevented from entering into cells to exert their effects. Therefore, it is of great significance to design effective drug carriers with a penetrating ability toward plasma membranes. In this study, a dual-templated MIP (dt-MIPs) carrier with controllable microstructure and high drug loading capacity was prepared using highly expressed sphingomyelin on the plasma membrane and tenofovir (TFV), a first-line drug for HIV and chronic hepatitis B, as template molecules. The drug release experiments performed in vitro under simulated physiological conditions demonstrated that sustained and stable adsorption of TFV on dt-MIPs was more than 80% over 50 h. By a combination of flow cytometry and confocal microscopy, dt-MIPs were found to have efficient cell permeability. Furthermore, mass-spectrometry-based intracellular pharmacokinetic studies demonstrated that TFV was delivered completely into cells within 30 min with the delivery of dt-MIPs. The study presented above suggested that dt-MIPs are expected to be alternative nanoscale drug carriers for enhanced drug permeability and controlled release.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Esfingomielinas
/
Portadores de Fármacos
/
Membrana Celular
Límite:
Humans
Idioma:
En
Año:
2024
Tipo del documento:
Article